{"disease":{"id":"seizures-focal","name":"seizures focal"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04770337","title":"Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy","phase":"NA","overall_status":"COMPLETED","enrollment_count":127,"lead_sponsor_name":"Neuroelectrics Corporation","has_results":false},{"nct_id":"NCT05248269","title":"Thermocoagulation in Drug Resistant Focal Epilepsy","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":75,"lead_sponsor_name":"State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia","has_results":false},{"nct_id":"NCT07139457","title":"Wearable Epileptic Seizure Prediction and Alert Glasses Based on Neuromorphic Computing","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":47,"lead_sponsor_name":"Oman Ministry of Health","has_results":false},{"nct_id":"NCT06492720","title":"A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy","phase":"NA","overall_status":"RECRUITING","enrollment_count":16,"lead_sponsor_name":"NaviFUS Corporation","has_results":false},{"nct_id":"NCT06388707","title":"A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":8,"lead_sponsor_name":"NaviFUS Corporation","has_results":false},{"nct_id":"NCT05738226","title":"EpiCare@Home Validation Study for Focal Onset Seizures","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Byteflies","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}